Epidemiology of major amputation following diabetic foot ulcer: Insights from recent nationwide data in the french national health registry (SNDS)

被引:0
作者
Bonnet, Jean-Baptiste [1 ,2 ]
Duflos, Claire [2 ,3 ]
Huguet, Helena [3 ]
Avignon, Antoine [1 ,2 ]
Sultan, Ariane [1 ,4 ]
机构
[1] Univ Hosp Montpellier, Nutr Diabet Dept, Montpellier, France
[2] Univ Montpellier, Desbrest Inst Epidemiol & Publ Hlth, INSERM, Joint Res Unit,UMR 1302, Montpellier, France
[3] Univ Montpellier, Clin Res & Epidemiol Unit, CHU Montpellier, Montpellier, France
[4] Univ Montpellier, Natl Ctr Sci Res CNRS, PhyMedExp, INSERM,U1046,Joint Res Unit,UMR 9214, Montpellier, France
关键词
Amputation; Diabetic foot ulcer; Epidemiology; French national health data system; PERIPHERAL ARTERY-DISEASE; PEOPLE; DEPRIVATION; MORTALITY; EVENTS; BURDEN; RISK;
D O I
10.1016/j.diabet.2025.101606
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The out-of-hospital care pathways of people with DFU have been little studied. We used the French National Health Data System (SNDS) to collect refund and care pathway data for all French residents. The aim of this study was to determine the incidence of major lower limb amputation (MA) and associated risk factors in a population with an incident DFU. Research Design and Methods: We included any person living with diabetes and incident DFU. The primary endpoint was the occurrence of MA within one year. We considered the course and consumption of care one year before and one year after the initial event. Results: In 2018, 133,791 people were included, and during the follow-up, MA was performed in 4,733 (3.5 %). Among these people with MAs, 16.4 % were included via the out-of-hospital part of the protocol, and their first contact with the hospital led to MA. Factors associated (hazard ratio, HR [95 % confidence interval, CI]) with MA were: being male (1.92 [1.78;2.08]), arteriopathy of the lower limb (10.16 [9.36;11.03]), psychiatric disease (1.10 [1.01;1.20]) and end-stage renal disease (2.12 [1.93;2.33]). Regarding the care pathway, associations (HR [95 %CI]) were observed between lower MA rates and people with more general practitioner (0.83 [0.75-0.91]), private nurse (0.88 [0.81-0.95]) and diabetologist (0.88 [0.81-0.95]) visits. Living in the most disadvantaged municipalities was associated (HR [95 %CI]) with a higher MA rate (1.17 [1.06-1.29]). Conclusion: This is the first national study of the care pathways followed by people with DFU. Failures in the care pathway, precariousness and several comorbidities were identified, with an impact on the MA risk.
引用
收藏
页数:8
相关论文
共 36 条
  • [1] Diabetic Foot Complications and Their Risk Factors from a Large Retrospective Cohort Study
    Al-Rubeaan, Khalid
    Al Derwish, Mohammad
    Ouizi, Samir
    Youssef, Amira M.
    Subhani, Shazia N.
    Ibrahim, Heba M.
    Alamri, Bader N.
    [J]. PLOS ONE, 2015, 10 (05):
  • [2] Less amputations for diabetic foot ulcer from 2008 to 2014, hospital management improved but substantial progress is still possible: A French nationwide study
    Amadou, Coralie
    Denis, Pierre
    Cosker, Kristel
    Fagot-Campagna, Anne
    [J]. PLOS ONE, 2020, 15 (11):
  • [3] Social deprivation modifies the association between incident foot ulceration and mortality in type 1 and type 2 diabetes: a longitudinal study of a primary-care cohort
    Anderson, Simon G.
    Shoo, Haika
    Saluja, Sushant
    Anderson, Christian D.
    Khan, Adnan
    Livingston, Mark
    Jude, Edward B.
    Lunt, Mark
    Dunn, George
    Heald, Adrian H.
    [J]. DIABETOLOGIA, 2018, 61 (04) : 959 - 967
  • [4] Diabetic Foot Ulcers A Review
    Armstrong, David G.
    Tan, Tze-Woei
    Boulton, Andrew J. M.
    Bus, Sicco A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (01): : 62 - 75
  • [5] "The Renal Foot" - Angiographic Pattern of Patients with Chronic Limb Threatening Ischemia and End-Stage Renal Disease
    Baghdasaryan, Patrick A.
    Bae, Jun Ho
    Yu, Wendy
    Rowe, Vincent
    Armstrong, David G.
    Shavelle, David M.
    Clavijo, Leonardo C.
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (01) : 118 - 121
  • [6] The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality
    Bannay, Aurelie
    Chaignot, Christophe
    Blotiere, Pierre-Olivier
    Basson, Mickael
    Weill, Alain
    Ricordeau, Philippe
    Alla, Francois
    [J]. MEDICAL CARE, 2016, 54 (02) : 188 - 194
  • [7] Barlet M., working papers DT51
  • [8] Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease A Meta-analysis of Randomized Trials
    Berger, Jeffrey S.
    Krantz, Mori J.
    Kittelson, John M.
    Hiatt, William R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (18): : 1909 - 1919
  • [9] Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study
    Bidulka, Patrick
    Mathur, Rohini
    Lugo-Palacios, David G.
    O'Neill, Stephen
    Basu, Anirban
    Silverwood, Richard J.
    Charlton, Paul
    Briggs, Andrew
    Smeeth, Liam
    Adler, Amanda, I
    Douglas, Ian J.
    Khunti, Kamlesh
    Grieve, Richard
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (01) : 282 - 292
  • [10] Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database
    Blin, Patrick
    Joubert, Michael
    Jourdain, Patrick
    Zaoui, Philippe
    Guiard, Estelle
    Sakr, Dunia
    Dureau-Pournin, Caroline
    Bernard, Marie-Agnes
    Lassalle, Regis
    Thomas-Delecourt, Florence
    Bineau, Sebastien
    Moore, Nicholas
    Droz-Perroteau, Cecile
    [J]. CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)